Pfizer and biontech granted fda fast track designation for two investigational mrna-based vaccine candidates against sars-cov-2

Pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx, “biontech”) today announced that two of the companies’ four investigational vaccine candidates

BNTX Ratings Summary

BNTX Quant Ranking